Salindawan, Mohadjera .
HRN: 22-65-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
AMPICILLIN 500MG (VIAL)
11/10/2023
11/17/2023
IV
350mg
Q 6hrs
Pcap C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes